Otis Brawley

The Scientist Date: September 1, 1997 "THE SCIENTIST helps me stay informed. No other journal writes so comprehensively about science and science policy." OTIS BRAWLEY, Director Office of Special Populations, National Cancer Institute Otis Brawley was given a job last June to help plan and guide the National Cancer Institute's (NCI's) agenda and ensure that the questions asked by NCI-sponsored scientists are pertinent to all Americans and that questions pertinent to women, the elderly, minorit

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: September 1, 1997

OTIS BRAWLEY, Director
Office of Special Populations,
National Cancer Institute

Otis Brawley was given a job last June to help plan and guide the National Cancer Institute's (NCI's) agenda and ensure that the questions asked by NCI-sponsored scientists are pertinent to all Americans and that questions pertinent to women, the elderly, minorities, and cancer survivors are addressed.

In working with mentors in medical school, Brawley learned that oncology is not a depressing specialty; it is still a relatively young specialty with many opportunities. He is one of the United States' few black medical oncologists who has written and run clinical trials. Since 1991, he has been involved with a prostate prevention trial involving more than 18,000 people. One of his goals is to increase public understanding of the advantages of clinical trials.

Of THE SCIENTIST, Brawley says: "THE SCIENTIST helps me stay informed. No ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies